AlphaYouMC
Insider selling
Mark C. Schneyer sold $587K of Acadia Pharmaceuticals Inc (ACAD) stock
Mark C. Schneyer, EVP, Chief Financial Officer of Acadia Pharmaceuticals Inc (ACAD), sold 20,141 shares of ACAD stock worth $587K, per an SEC Form 4 filed Aug 7, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 5, 2026, 2 days before it was made public.
ACAD has moved -8.4% since the trade date, from $28.80 to $26.39 (Sep 21, 2026 close).
- Traded
- Aug 5, 2026
- Disclosed
- Aug 7, 2026
- Filing delay
- 2 days
- Price since
- -8.4%
- Role
- EVP, Chief Financial Officer
- Source
- SEC Form 4
More ACAD insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.